Company profile
Catalent Nottingham Limited
Leading Global CDMO for Pharma & Biotech | Catalent
Providing CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.
Corporate ownership
Updated 07 Jul 2026 09:49
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQ0MzU2MzkyM2FkaXF6a2N4
Published 15 Nov 2024 12:54
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Accelerating paediatric formulation development through smart design and predictive science
1 Jul 2014 to 31 Mar 2018
This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot ...
PAT
1 Sep 2013 to 31 Aug 2015
Awaiting Public Project Summary
Regenerative Matrices for Orthopaedic Repair
1 Jul 2010 to 31 Mar 2011
Awaiting Public Summary